We are live on ! Find out more
SGYPW

Synergy Pharmaceuticals, Inc. - Warrants

Delisted

SGYPW was delisted on the 6th of December, 2016.

5 hedge funds and large institutions have $1.57M invested in Synergy Pharmaceuticals, Inc. - Warrants in 2013 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

161% more capital invested

Capital invested by funds: $600K → $1.57M (+$968K)

150% more funds holding

Funds holding: 25 (+3)

Holders
5
Holders Change
+3
Holders Change %
+150%
% of All Funds
0.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$806K
SM
2
Sabby Management
Florida
$751K +$575K +349,217 New
CAL
3
Capital Advisors Ltd
Ohio
$10K +$2.96K +1,799 New
U
4
UBS
Switzerland
$1K +$1.01K +615 New
TRCT
5
Tower Research Capital (TRC)
New York
+$66 +40 +100%

SGYPW Hedge Fund Activity: Q4 2013 in Review

5 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) for Q4 2013, worth a combined $1.57M — up 161% from $600K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new SGYPW positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $575K.

  • 5 institutional investors held Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) as of Q4 2013, up from 2 in Q3 2013.
  • Funds reported $1.57M of Synergy Pharmaceuticals, Inc. - Warrants stock for Q4 2013, up 161% quarter-over-quarter.
  • 3 funds opened new Synergy Pharmaceuticals, Inc. - Warrants positions in Q4 2013 and 0 closed out, a net change of +3 holders.
  • The largest Synergy Pharmaceuticals, Inc. - Warrants buyer in Q4 2013 was Sabby Management, an estimated $575K added.

Based on aggregated 13F filings for Q4 2013.